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Abstract
Regulation of pre-mRNA splicing is achieved through the interaction of RNA sequence elements and a variety of RNA-
splicing related proteins (splicing factors). The splicing machinery in humans is not yet fully elucidated, partly because
splicing factors in humans have not been exhaustively identified. Furthermore, experimental methods for splicing factor
identification are time-consuming and lab-intensive. Although many computational methods have been proposed for the
identification of RNA-binding proteins, there exists no development that focuses on the identification of RNA-splicing
related proteins so far. Therefore, we are motivated to design a method that focuses on the identification of human splicing
factors using experimentally verified splicing factors. The investigation of amino acid composition reveals that there are
remarkable differences between splicing factors and non-splicing proteins. A support vector machine (SVM) is utilized to
construct a predictive model, and the five-fold cross-validation evaluation indicates that the SVM model trained with amino
acid composition could provide a promising accuracy (80.22%). Another basic feature, amino acid dipeptide composition, is
also examined to yield a similar predictive performance to amino acid composition. In addition, this work presents that the
incorporation of evolutionary information and domain information could improve the predictive performance. The
constructed models have been demonstrated to effectively classify (73.65% accuracy) an independent data set of human
splicing factors. The result of independent testing indicates that in silico identification could be a feasible means of
conducting preliminary analyses of splicing factors and significantly reducing the number of potential targets that require
further in vivo or in vitro confirmation.
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Introduction
Alternative splicing (AS), in eukaryotes, is one of the
mechanisms of post-transcriptional regulation that generate
multiple transcripts from the same gene. These transcripts are
then translated into multiple proteins having diverse biological
functions. According to the comparative alignment of EST
sequences and high-throughput biotechnology techniques such
as exon/exon-junction array and RNA-Seq, it has been revealed
that most genes (larger than 90%) undergo alternative splicing in
humans [1,2,3,4]. In general, alternative splicing is regulated by
splicing factors (SF) that recognize and associate with specific RNA
sequence elements in order to enhance or repress the ability of the
spliceosome to recognize nearby splice sites [5,6]. More precisely,
the mechanism is finished through many of the positive or negative
trans-acting splicing factors which are recruited to the enhancer or
silencer cis-acting sequence elements of the pre-mRNA, such as
exonic splicing enhancer (ESE), exonic splicing silencer (ESS),
intronic splicing enhancer (ISE) and intronic splicing silencer (ISS)
[7,8,9]. Meanwhile, the process exploits the dynamic composition
of splicing factors under various cell lines or developmental stages
to have flexible intermolecular interactions such as protein-RNA,
RNA-RNA, and protein-protein interactions [10,11,12]. Cancer
cells often take advantage of this flexibility to produce proteins that
promote growth and survival [13].
Eukaryotic messenger RNAs (mRNAs) are produced by
accurately removing introns from precursors (pre-mRNAs) in a
process called RNA splicing. RNA splicing is required for typical
eukaryotes that produce mature mRNA before it can be used to
code a correct protein through translation. The eukaryotic RNA
splicing is done in a series of reactions that are catalyzed by the
spliceosome, which is a collection of small nuclear RNAs (snRNAs)
and proteins recruited to pre-mRNAs for carrying out intron
excision [14,15]. With the comprehensively biochemical and
genetic studies in a variety of biological systems, spliceosomes have
been revealed to contain five essential snRNAs, each of which
functions as an RNA–protein complex called a small nuclear
ribonucleoprotein (snRNP) [16,17]. RNAs and proteins cooperate
extensively in ribonucleoproteins (RNPs) to bring about the
biological functions of splicing machinery [11]. Two types of
spliceosomes have been identified for eukaryotes: one is U2-type
spliceosome, which consists of U1, U2, U4, U5, and U6 snRNPs;
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U12, U4atac, U5, and U6atac snRNPs [16]. The U2-type
spliceosome catalyzes the removal of most introns and U12-type
spliceosome recognizes less than 1% of human introns [18].
Regulation of pre-mRNA splicing is achieved through the
interaction of RNA sequence elements and a variety of RNA-
splicing related proteins (splicing factors) [19,20]. Within the
assembled spliceosome, intron excision contains two major
chemical steps: the first step refers to the 59 splice site cleavage
and lariat formation; the second step refers to the 39 splice site
cleavage and exon ligation [14]. The initial event of RNA splicing
is the recognition of specific sequences located at the 59 and 39
splice sites by splicing factors [21], which determines the intron
boundaries. One of the well-known protein families of splicing
factors in terms of serine- and arginine-rich carboxy-terminal
domains is the SR proteins. This protein family consists of at least
five different proteins with molecular masses of 20, 30, 40, 55, and
75 kD [15]. However, although the introns are excised with a high
degree of precision, the splice site sequences are weakly conserved
[16,22]. The alternative selection of splice sites (alternative
splicing) present within a pre-mRNA, leads to the production of
multiple mRNAs from a single gene [13].
Due to the multiplicity of protein–protein and protein–RNA
interactions that modulate the associations between splicing factors
and pre-mRNAs, the first mass spectrometry-based analysis of in
vitro-derived spliceosomes was limited to species visible in stained
2D-gels. This analysis was able to identify 17 previously known
splicing factors (including hnRNP proteins) and 23 novel splicing-
related proteins [23]. Although previous works have identified
more than 200 human splicing factors based on comprehensive
proteomic analysis [24,25], many of the newly identified proteins
have not yet been experimentally verified to function in pre-
mRNA splicing [16]. Without functional validation, it would be
premature to label all of these proteins as bona fide splicing
factors. A previous work by Jurica and Moore [14] have manually
conducted about 180 human splicing factors by literature survey.
Due to the importance of splicing factors in pre-mRNA splicing,
more attention is being paid to mass spectrometry-based
proteomic studies [19,24,25,26,27], which has been observed to
identify an increasing number of experimentally verified splicing
factors. However, experimental identification is proven to be time-
consuming and lab-intensive. Thus, in silico investigation has the
potential for characterizing splicing factors prior to experimental
verification. Over the last few years, several studies have been
proposed to computationally predict RNA-binding proteins
[28,29]. Additionally, many computational methods have been
developed to identify RNA-binding residues on protein sequences
[30,31,32,33,34,35,36,37,38,39]. In particular, SFmap [21], a web
server for predicting putative splicing factor binding sites in
genomic data, utilizes a modified Hamming distance formula to
define a match between a splicing factor sequence query and a
target sequence. The distance scores are then standardized and a
Z-score is obtained for calculating the significance of each query
relative to a background model which is then compared to a
threshold value in order to give a probable prediction. Another
work done by Barbosa-Morais et al. [16] presents a semi-
automated computational pipeline to aid in identifying and
annotating spliceosomal proteins. The proposed method utilizes
annotated human splicing factors grouped into families based on
full-length homology, functional domain, and Ensembl protein
family classification which are then transformed into phylogenetic
trees. Their work has revealed more than 200 proteins of multiple
organisms for which there is experimental evidence regarding its
involvement in splicing. Furthermore, a related work by Zheng
et al. [40] proposed a method which utilizes support vector
machine, a binary-class classification algorithm, to construct a
model for discriminating transcription factors (TFs) from non-TFs
using protein domain and functional site information. The authors
have also employed error-correcting output coding, a multi-class
classification algorithm, in order to classify the identified TFs
according to: basic-TFs, zinc-TFs, helix-TFs, and beta-TFs. These
published works have demonstrated their accuracy and stability;
however, there is no fully computational method developed to
identify splicing factors based on protein sequences so far.
Therefore, we are motivated to develop a novel method focusing
on the identification of human splicing factors using the
experimentally verified spliceosomal proteins and RNA-splicing
related proteins.
In this study, the experimentally validated human splicing
factors have been collected from two previously published
literatures [14,16]. This work not only investigates the composition
of amino acids on splicing factors, but also considers evolutionary
information through a position-specific scoring matrix (PSSM).
The explored features are used to construct a predictive model for
differentiating splicing factors from non-splicing proteins. A
support vector machine (SVM) is used to construct a predictive
model with various features. Moreover, the information of
functional domains extracted from InterPro [41] is also adopted
to improve the prediction scheme. Finally, an independent test set,
which is not included in the training set, is also constructed to
evaluate whether the predictive model is over-fitted to the training
set.
Materials and Methods
Figure 1 presents the system flow of the proposed method. It
consists of the following steps: data collection and pre-processing,
feature extraction, model learning and cross-validation, and
independent testing. The details of each process are described as
follows.
Data collection and pre-processing
The experimentally verified splicing factors in humans were
collected from published literatures [14,16]. Jurica and Moore
[14] have proposed about 180 manually curated splicing factors in
humans by literature survey. In addition, Barbosa-Morais et al.
[16] have proposed more than 200 splicing factors from multiple
organisms by an integrative method incorporating systematic
pipeline and experimental evidence. After the removal of
redundant protein entries, it resulted in a total of 283 human
splicing factors which are regarded as positive data for feature
investigation and model training. Furthermore, human proteins
which are not among the positive data obtained from literature
were extracted from the UniProt protein knowledge base [42] by
running a search on UniProt IDs using the keyword ‘‘HUMAN’’.
To construct the positive data of independent testing, only
experimentally verified splicing factors are obtained from the
resulting dataset by collecting protein entries annotated as ‘‘RNA
splicing’’, ‘‘spliceosome’’, or ‘‘splicing factors’’. UniProt uses such
annotations to define a protein entry that has been experimentally
identified to be essential for RNA splicing. This yielded 99 protein
sequences which are then regarded as positive data for
independent testing. In order to filter out potential noise data
for non-splicing proteins, the remaining proteins consisting of
keyword ‘‘RNA-binding’’ are removed. As a result, a total of
19512 proteins are regarded as negative data.
In classifying splicing factors and non-splicing proteins, there is
a possibility that the prediction performance of the constructed
Identification of RNA Splicing Factors in Humans
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Therefore, an independent test set is used to estimate the actual
prediction performance. However, there may be a possible
overestimation in the prediction performance due to homologous
sequences found in the training data and independent test data.
With reference to the work by Panwar et al. [43], homologous
sequences from the collected data are removed by using CD-HIT.
CD-HIT firstly forms a cluster with a representative sequence
having the longest length which is then compared to the remaining
sequences. If the similarity between a target sequence and the
representative sequence is above the user-selected sequence
identity threshold which refers to the pairwise sequence identity
between two proteins, then the target sequence is considered
homologous to the representative sequence [44]. Different values
were tested for the sequence identity parameter as shown in
Table 1. The resulting dataset given a sequence identity parameter
of 30% contains 173 positive sequences of training set, 65 positive
sequences of independent test set, and 11113 negative sequences.
The negative data is then randomly divided into two sets – 5557
protein sequences are regarded as negative data for model
training, and 5556 protein sequences are regarded as negative
data for independent testing.
Feature extraction
Compositions of amino acids and amino acid dipep-
tide. Each protein sequence in the data set is represented using a
vector {xi, i=1,…,n} labeled according to its corresponding
protein group (e.g. splicing factor or non-splicing protein). The
vector xi has 20 elements for the amino acid composition and 400
elements for the amino acid dipeptide composition. For amino
acid composition, the 20 elements specify the numbers of
occurrences of 20 amino acids normalized with the total number
of residues in the protein. On the other hand, for amino acid
dipeptide composition, the 400 elements specify the numbers of
occurrences of 400 amino acid dipeptides normalized with the
total number of dipeptides in the protein.
Statistically significant amino acid dipeptides. In further
exploring potential features for protein classification, various
methods aimed at selecting relevant sequence features given a
large set of features have been used [45]. In this work, the
importance of amino acid dipeptides in identifying splicing factors
is further investigated by means of measuring the statistical
significance of each dipeptide in the data set. For each amino acid
dipeptide, the number of splicing factors and non-splicing proteins
containing the target dipeptide is calculated separately. The
statistical significance of each dipeptide is then obtained by
examining a sample against a background set based on the
hypergeometric equation (P-value) [46]:
P(t)~
X T
t
CT
t :CK{T
k{t
CK
k
ð1Þ
where K is the background set represented by the number of all
proteins and T is the sample set represented by the number of
splicing factors; k is the number of all proteins having the target
amino acid dipeptide and t is the number of splicing factors having
the target amino acid dipeptide. P-value is calculated for each
dipeptide based on the hypergeometric equation. A smaller p-value
corresponds to a greater statistical significance. Furthermore, the
positive and negative probabilities of each amino acid dipeptide
are computed by means of dividing the number of splicing factors
or non-splicing proteins having the target amino acid dipeptide by
the total number of splicing factors or non-splicing proteins,
respectively. The probability difference between the positive and
the negative probability is then obtained. In this work, amino acid
Figure 1. System Flow.
doi:10.1371/journal.pone.0027567.g001
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difference greater than 0 is considered as statistically informative
for the identification of splicing factors.
Evolutionary information. Several amino acid residues of a
protein can go through mutation without changing its structure,
and two proteins may share similar structures with different amino
acid compositions. In this work, evolutionary information is
obtained using position-specific scoring matrix (PSSM). PSSM
profiles have been extensively utilized in protein secondary
structure prediction, subcellular localization and other approa-
ches in bioinformatics [47,48,49]. The PSSM profiles of each
protein were obtained by using PSI-BLAST search against the
non-redundant database of protein sequences compiled by NCBI
[50]. Due to the fact that the data consists of protein sequences
with variable length, a weighted score of features is obtained by
summing up the position-specific scores of the same amino acids
occurring in a protein sequence to get a uniform number of
features. Figure 2 displays in detail how to generate a 400-
dimensional (20620 residue pairs) PSSM feature vector for each
splicing factor and non-splicing protein. PSSM profile is a matrix
of m620 elements where m represents the protein sequence length
and 20 represents the position specific scores for each type of
amino acid. Then, the PSSM profile is transformed to a 20620
matrix by summing up each row of same amino acid in the PSSM
profile and the variable is denoted as ‘‘x’’. Finally, every element of
400-dimensional PSSM vector is divided by the length of the
sequence and then is scaled by
1
1ze{x for normalizing the values
between 0 and 1.
Table 1. Data abundancy after using CD-HIT.
Sequence identity Positive data of training set Positive data of independent test set Negative data
100% (original) 283 99 19512
90% 274 94 18897
80% 268 94 18447
70% 256 94 17727
60% 242 88 16710
50% 226 82 15255
40% 202 80 13333
30% 173 65 11113
doi:10.1371/journal.pone.0027567.t001
Figure 2. The detailed process of generating 400-dimensional PSSM vector by the PSSM profile.
doi:10.1371/journal.pone.0027567.g002
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doi:10.1371/journal.pone.0027567.g003
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protein prediction have exhibited the ability of distinguishable
domain regions in the classification of proteins [45]. In this work,
domain information is investigated as a feature for classifying
splicing factors from non-splicing proteins. To investigate the
preference of functional domains in splicing factors, this study
referred to the annotations in InterPro [41]. InterPro is an
integrated resource, which was developed initially as a means of
rationalizing the complementary efforts of the PROSITE [51],
PRINTS [52], Pfam [53], and ProDom [54] databases, for
providing protein ‘‘signatures’’ such as protein families, domains
and functional sites. The domain information of each splicing
factor in the training data is collected by referring to its
corresponding InterPro ID in the UniProt database. The
collected domains are then analyzed in order to identify the
most distinguishable domains in splicing factors. For this work,
functional domains present in more than five splicing factors are
considered as significant domains.
Feature Combination. A hybrid approach is investigated in
this work by combining different sets of feature vectors with the goal
of improving splicing factor prediction performance. Three types of
hybrid combinations are explored. In the first combination, the
effect of combining PSSM with the composition-based features is
explored. In the second combination, the effect of combining
domain information with the composition-based features is
explored. In the third combination, the effect of combining both
PSSM and domain information with the composition-based
features is explored.
Model learning and cross-validation evaluation
Support vector machine (SVM) is applied to generate
computational models that incorporate the encoded set of features.
Based on binary classification, the concept of SVM is to map the
input samples into a higher dimensional space using a kernel
function, and then to find a hyper-plane that discriminates
between the two classes with maximal margin and minimal error.
A public SVM library, LibSVM [55], is used to train the predictive
model with positive and negative training sets, which are encoded
with reference to various training features. The radial basis
function (RBF) K(Si,Sj)~exp({c Si{Sj
       2) is selected as the
kernel function of SVM. Cross-validation is important to the
application of the predictor [56]. The predictive performance of
the constructed models is evaluated by performing k-fold cross
validation. The training data is divided into k groups by splitting
each dataset into k approximately equal sized subgroups. In this
work, k is set to five. During cross-validation, each subgroup is
regarded as the validation set in turn, and the remainder is
regarded as the training set. Next, the following measures of
predictive performance of the trained models are defined:
Sensitivity (Sn)~
TP
TPzFN
, ð2Þ
Specificity (Sp)~
TN
TNzFP
, ð3Þ
Accuracy (Acc)~
TPzTN
TPzFNzTNzFP
, ð4Þ
where TP, TN, FP and FN represent the numbers of true positives,
true negatives, false positives and false negatives, respectively.
Additionally, the parameters of the predictive model, cost and
gamma value of the SVM models are optimized to maximize
predictive accuracy. In optimization of SVM parameter C and
RBF kernel parameter gamma, the grid search is applied to obtain
the parameters that achieve the best accuracy during k-fold cross-
validation. Then, the hybrid combinations of features that yield
the highest accuracy are employed to construct predictive models
for independent testing. Finally, the SVM model trained with the
combined features and the selected parameters (C and gamma) are
evaluated the predictive performance using independent testing
data.
Independent testing
In order to further evaluate the trained models, an independent
test set from humans is obtained as discussed previously, resulting
in 65 positive data and 5556 negative data shown in Table 1. In
addition, this work also investigates the ability of the predictive
model to identify splicing factors from other mammalian species
(File S1).
Results and Discussion
Investigation of amino acid composition in splicing
factors
The difference between splicing factors and non-splicing
proteins is analyzed in terms of its amino acid composition as
shown in Figure 3. It can be observed that splicing factors are
significantly distinguishable from non-splicing proteins at the
amino acid composition level. For instance, Arginine (R), Aspartic
Acid (D), Glutamic Acid (E), Glycine (G), Leucine (L), and Lysine
(K) residues all exhibit a remarkable difference between splicing
factors and non-splicing proteins. The dominance of these amino
acid residues indicates its contribution in RNA-protein and
protein-protein interactions. Among these residues, the abundance
of R and K in splicing factors is reasonable because these positively
charged residules can easily interact with negatively charged RNA.
Another abundant amino acid group observed in splicing factors is
D and E which are negatively charged residues and are easily
located on surface area of a protein for interacting with other
splicing factors. Interestingly, the small size and flexibility of G
residue is probably responsible for making it suitable for the
structural adjustments required during the protein-protein inter-
actions [37]. Furthermore, Leucine (L) is observed to be the most
prominent among all under-representated residues. In order to
examine the effectiveness of amino acid composition in identifying
splicing factors, an SVM model is trained using a 20-dimensional
vector consisting of the composition scores for twenty amino acids.
The amino acid composition-based model is evaluated by means
of five-fold cross-validation. As shown in Table 2, the model
Table 2. Five-fold cross validation performance of basic
features.
Features Sensitivity Specificity Accuracy
Amino acid composition 76.90% 80.33% 80.22%
Dipeptide composition 78.62% 78.53% 78.53%
Statistically significant
dipeptides
76.31% 79.07% 78.98%
PSSM 79.81% 79.48% 79.49%
Functional domain 38.75% 93.82% 92.16%
doi:10.1371/journal.pone.0027567.t002
Identification of RNA Splicing Factors in Humans
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27567achieved 76.90% sensitivity, 80.33% specificity, and 80.22%
accuracy.
Investigation of amino acid dipeptide composition in
splicing factors
Previous studies have exhibited that dipeptide composition-
based methods can yield a better performance as compared to
amino acid composition-based methods [43,57]. In order to
investigate this claim in terms of identifying splicing factors, an
SVM model is trained using amino acid dipeptide composition as
features. Firstly, the composition of all possible amino acid pairs is
calculated in splicing factors and non-splicing proteins, respec-
tively. Thus, each protein sequence can be encoded as a 400-
dimensional vector consisting of the composition scores for 20620
amino acid pairs. Using the resulting 400-dimensional dipeptide
vectors, an SVM model is trained and is evaluated by means of
five-fold cross-validation. The dipeptide composition-based model
achieved 78.62% sensitivity, 78.53% specificity, and 78.53%
accuracy as shown in Table 2. It can be observed that the amino
acid composition-based method yields higher accuracy in
Figure 4. Probability difference of 20620 amino acid pairs between splicing factors and non-splicing proteins. The amino acid pair
with red box indicates an over-representation in splicing factors; on the other hand, green box means an under-representation.
doi:10.1371/journal.pone.0027567.g004
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yields a more balanced sensitivity and specificity.
Theaminoaciddipeptidecompositionofsplicingfactorsandnon-
splicing proteins is further analyzed by means of selecting statistically
significant dipeptides among the 400 amino acid pairs. Figure 4
shows the probability difference of 400 amino acid pairs between
splicing factors and non-splicing proteins. In the 20620 matrix,
amino acid pairs marked in red indicates over-representation in
splicing factors while amino acid pairs marked in blue indicates
under-representation. It can be observed in Figure 4 that DD pairs
are over-represented in splicing factors as well as D residues paired
with E, R, and K. Also, KK pairs are observed to be over-
represented in splicing factors. Furthermore, it can also be observed
that Cysteine (C) residues paired with other resides are under-
represented in splicing factors. The P-value and the probability
difference of each amino acid dipeptide is calculated as discussed
previously. After ranking the dipeptides according to P-value, each
amino acid pair having a P-value,0.05 and a probability difference
.0 is considered as a statistically significant pair. A total of 64 pairs
areselectedamongthe400aminoacidpairs.Interestingly,itisfound
that these observations in Figure 4 coincide with the selected 64
significant pairs based on P-value (File S2).
An SVM model is trained using a 64-dimensional vector
consisting of the composition scores for the selected 64 statistically
significant amino acid dipeptides. The model is evaluated by means
of five-fold cross-validation. As shown in Table 2, the statistically
significant dipeptide-based model achieved 76.31% sensitivity,
79.07% specificity, and 78.98% accuracy. It can be concluded that
the method used for selecting statistically significant dipeptides was
able to select the features that mostly distinguish splicing factors
from non-splicing proteins. Also, the method was able to maintain a
performance similar to that yielded by using all 400 amino acid
composition features. In line with this, it can be assumed that the
dipeptides not selected by the method do not significantly
distinguish splicing factors from non-splicing proteins.
Investigation of evolutionary information
It has been shown in previous works that using evolutionary
information encapsulated in a PSSM profile provides a more
comprehensive information as compared to single sequence features
[37]. In this work, the application of evolutionary information is
investigated in terms of identifying splicing factors by training an
SVM model using a 400-dimensional vector derived from the
PSSM profile of each protein sequence. A PSSM profile is the
probability of the occurrence of each type of amino acid residues at
each position along with insertion/deletion. Hence, PSSM is
regarded as a measure of residue conservation in a given protein
sequence. As shown in Table 2, the PSSM-based model achieved
79.81% sensitivity, 79.48% specificity, and 79.49% accuracy.
Investigation of functional domain information in
splicing factors
In order to analyze functional domain information in splicing
factors, the experimentally verified domains of each splicing
factor in the training data is collected by referring to the
‘‘InterPro’’ field in UniProt. This resulted to a a total of 252
functional domains existing in splicing factors. In order to capture
the representative functional domains in splicing factors,
functional domains which are present in more than 5 splicing
factors are selected as distinguishable domains. This resulted to
15 functional domains as shown in Table 3. It is observed that the
most distinguishable functional domain is the ‘‘Nucleotide-bd a/b
plait’’ with InterPro ID: IPR012677 which exists in 46 splicing
factors. Another distinguishable functional domain is the ‘‘RRM’’
domain with InterPro ID: IPR000504 which exists in 45 splicing
factors. In order to evaluate the performance of using the selected
distinguishable domains, an SVM model is trained using a 15-
dimensional vector consisting of the 15 distinguishable domains
represented by a binary score: 1 if present and 0 otherwise. As
shown in Table 2, the domain-based model achieved 38.75%
sensitivity, 93.82% specificity, and 92.16% accuracy. It can be
observed that using domain information alone is not sufficient to
correctly identify all splicing factors as seen in the low sensitivity
of the prediction model. As discussed previously, only those
functional domains present in more than 5 splicing factors are
considered by the model. This affected the prediction of true
positives due to the fact that many splicing factors are not
annotated with the selected functional domains. This may later
improved given a more comprehensive InterPro annotation on
the dataset. On the other hand, the high specificity yielded by the
model signifies that the selected functional domains are
meaningful since they do not exist in most of the non-splicing
proteins.
Cross-validation performance using hybrid features
The composition-based features are combined with PSSM
and domain information in order to investigate the effects of
incorporating evolutionary information and domain informa-
tion. Three types of hybrid combinations are explored in this
study: the first type refers to the combination of basic sequence
information with evolutionary information; the second type
refers to the combination of basic sequence information with
domain information; and the third type refers to the combina-
tion of basic sequence information with both evolutionary
information and domain information. An SVM model is trained
using each set of hybrid feature combination. As shown in
Table 4, the amino acid composition-based model improved
Table 3. Statistics of InterPro functional annotations in 173
splicing factors.
InterPro ID Description
Number of
splicing factors
IPR012677 Nucleotide-bd a/b plait 46
IPR000504 RRM domain 45
IPR010920 LSM-related domain 11
IPR001163 LSM domain 11
IPR006649 LSM domain euk/arc 10
IPR015943 WD40/YVTN repeat-like domain 10
IPR001680 WD40 repeat 9
IPR011046 WD40 repeat-like domain 9
IPR019782 WD40 repeat 2 9
IPR017986 WD40 repeat domain 9
IPR019781 WD40 repeat sg 9
IPR015880 Znf C2H2-like 7
IPR019775 WD40 repeat CS 7
IPR020472 G-protein beta WD-40 repeat 6
IPR013083 Xnf RING/FYVE/PHD 6
InterPro classifies sequences at superfamily, family and subfamily levels and
annotates the occurrence of functional domains, repeats and important sites.
The annotations which occur in more than five splicing factors are presented
with the information of InterPro ID, description, and number of splicing factors.
doi:10.1371/journal.pone.0027567.t003
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accuracy when combined with the evolutionary information
from PSSM profiles. Both dipeptide composition and statisti-
cally significant dipeptides-based models also improved with
79.81% sensitivity, 78.46% specificity, and 79.47% accuracy
when combined with evolutionary information. With regard to
incorporating basic features with domain information, the
amino acid composition-based model yields a lower perfor-
mance with 75.15% sensitivity, 82.94% specificity, and 82.04%
accuracy. This is the same for the dipeptide composition-based
model which yields 75.76% sensitivity, 77.34% specificity, and
77.29% accuracy. The statistically significant dipeptides-based
model also yields a lower performance with 75.12% sensitivity,
76.96% specificity, and 76.91% accuracy. Furthermore, incor-
porating both domain and evolutionary information with
statistically significant dipeptides gives the highest performance
with 82.68% sensitivity, 81.78% specificity, and 81.81%
accuracy. It is interesting to find that the three models
converged at the same performance after incorporating both
evolutionary and domain information.
Independent testing
The method is further evaluated by using an independent data
set composed of collected human splicing factors and non-splicing
proteins as discussed previously. The independent data is first
tested on each model trained on single features as shown in
Table 5. It can be observed that the amino acid composition-based
model yields a lower performance with 68.07% sensitivity, 68.17%
specificity, and 68.17% accuracy as compared to the models based
on dipeptide composition and statistically significant dipeptides.
The dipeptide composition-based model performs with 69.61%
sensitivity, 69.64% specificity, and 69.63% accuracy while the
statistically significant dipeptides-based model performs slightly
higher with 69.61% sensitivity, 70.46% specificity, and 70.45%
accuracy. With regard to the use of evolutionary information, the
PSSM-based model achieved the highest performance among all
single feature-based models with 72.69% sensitivity, 72.20%
specificity, and 72.21% accuracy. On the other hand, similar to
its cross-validation performance, the domain-based model per-
formed with a low sensitivity of 21.53%, 93.63% specificity, and
92.79% accuracy.
The independent data is then tested on the models based on
hybrid feature combinations. As presented in Table 6, the amino
acid composition-based model improved in classifying the
independent data with 72.69% sensitivity, 72.16% specificity,
and 72.17% accuracy when combined with the evolutionary
information from PSSM profiles. Both dipeptide composition
and statistically significant dipeptides-based models also im-
proved with 72.69% sensitivity, 72.20% specificity, and 72.21%
accuracy when combined with evolutionary information. With
regard to incorporating basic features with domain information,
the amino acid composition-based model yields a slightly lower
performance on the independent data with 68.07% sensitivity,
68.10% specificity, and 68.10% accuracy. The statistically
significant dipeptides-based model also yields a lower perfor-
mance with 66.53% sensitivity, 66.57% specificity, and 66.57%
accuracy. On the other hand, the dipeptide composition-based
model slightly improved with 68.07% sensitivity, 70.53%
specificity, and 70.50% accuracy. Furthermore, incorporating
both domain and evolutionary information to the basic feature-
based models gives the highest performance with 74.23%
sensitivity, 73.64% specificity, and 73.65% accuracy. Similar to
the cross-validation performance, incorporating both domain
information and evolutionary information on the three basic
models allowed it to converge at the same prediction perfor-
mance.
Conclusion
Although the importance of splicing factors has been indicated
in pre-mRNA splicing and alternatively splicing, in vivo or in vitro
identification of splicing factors are subject to technical limitations.
Table 5. Predictive performance of basic features on an
independent testing data.
Features Sensitivity Specificity Accuracy
Amino acid composition 68.07% 68.17% 68.17%
Dipeptide composition 69.61% 69.64% 69.63%
Statistically significant dipeptides 69.61% 70.46% 70.45%
PSSM 72.69% 72.20% 72.21%
Functional domain 21.53% 93.63% 92.79%
doi:10.1371/journal.pone.0027567.t005
Table 4. Five-fold cross-validation performance of hybrid features.
Hybrid features Sensitivity Specificity Accuracy
Incorporating PSSM with
Amino acid composition 77.47% 82.94% 81.77%
Dipeptide composition 79.81% 78.46% 79.47%
Statistically significant dipeptides 79.81% 78.46% 79.47%
Incorporating Domain information with
Amino acid composition 75.15% 82.25% 82.04%
Dipeptide composition 75.76% 77.34% 77.29%
Statistically significant dipeptides 75.12% 76.96% 76.91%
Incorporating both PSSM and Domain with
Amino acid composition 82.68% 81.77% 81.79%
Dipeptide composition 82.68% 81.77% 81.79%
Statistically significant dipeptides 82.68% 81.78% 81.81%
doi:10.1371/journal.pone.0027567.t004
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factors on the basis of amino acid sequence of a protein. With
reference to two previously published works, a total of 283
experimentally verified human splicing factors have been obtained
in in this study. After the removal of homologous sequences, the
investigation of amino acid composition reveals that there are
remarkable differences between splicing factors and non-splicing
proteins. The most prominent feature is the abundance of
positively and negatively charged residues in splicing factors.
Another important characteristic is the slight enrichment of G
residues in splicing factors. A five-fold cross-validation evaluation
has demonstrated that using amino acid composition could
provide a promising prediction accuracy. Another basic feature,
amino acid dipeptide composition, is also examined that has
similar predictive performance to amino acid composition.
Moreover, this method has presented that the evolutionary
information could provide a balanced predictive performance,
but the domain information resulted in low sensitivity and high
specificity. However, the incorporation of evolutionary informa-
tion and domain information improve the predictive performance
compared to the models trained with basic features. Additionally,
the independent testing has demonstrated that the constructed
model can identify new splicing factors in human proteome, as
well as in mouse and rat (File S1). Although several approaches
have been proposed to computationally predict RNA-binding
proteins [28,29], these methods, such as the web server RNApred
[28], provide a high sensitivity but a very low specificity using the
collected human independent testing data.
The biological process of RNA splicing machinery has not yet
been fully elucidated, partly because splicing factors are not yet
exhaustively identified. The recent genome-wide sequencing
techniques [16,19,26] provide an opportunity to exhaustively
observe splicing factors in an organism. This work shows that the
in silico identification could be a feasible means of conducting
preliminary analyses as well as significantly reducing the number
of potential targets that require further in vivo or in vitro
confirmation.
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